This work is licensed under the Creative Commons Attribution 4.0 International License.
Greenblatt DJ, Shader RI, Abernethy DR. Current status of benzodiazepines. N Engl J Med 1983;309:410–6. doi: 10.1056/NEJM198308183090705GreenblattDJShaderRIAbernethyDRCurrent status of benzodiazepinesN Engl J Med1983309410610.1056/NEJM198308183090705Open DOISearch in Google Scholar
Stewart SA. The effects of benzodiazepines on cognition. J Clin Psychiatry 2005;66(Suppl 2):9–13. PMID: 15762814StewartSAThe effects of benzodiazepines on cognitionJ Clin Psychiatry200566Suppl 291315762814Search in Google Scholar
Fisher J, Sanyal C, Frail D, Sketris I. The intended and unintended consequences of benzodiazepine monitoring programmes: a review of the literature. J Clin Pharm Ther 2012;37:7–21. doi: 10.1111/j.1365-2710.2011.01245.xFisherJSanyalCFrailDSketrisIThe intended and unintended consequences of benzodiazepine monitoring programmes: a review of the literatureJ Clin Pharm Ther20123772110.1111/j.1365-2710.2011.01245.xOpen DOISearch in Google Scholar
O'Connor LC, Torrance HJ, McKeown DA. ELISA detection of phenazepam, etizolam, pyrazolam, flubromazepam, diclazepam and delorazepam in blood using Immunalysis® benzodiazepine kit. J Anal Toxicol 2016;40:159–61. doi: 10.1093/jat/bkv122O'ConnorLCTorranceHJMcKeownDAELISA detection of phenazepam, etizolam, pyrazolam, flubromazepam, diclazepam and delorazepam in blood using Immunalysis® benzodiazepine kitJ Anal Toxicol2016401596110.1093/jat/bkv122Open DOISearch in Google Scholar
Villain M, Concheiro M, Cirimele V, Kintz P. Screening method for benzodiazepines and hypnotics in hair at pg/mg level by liquid chromatography-mass spectrometry/mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2005;825:72–8. doi: 10.1016/j.jchromb.2004.12.036VillainMConcheiroMCirimeleVKintzPScreening method for benzodiazepines and hypnotics in hair at pg/mg level by liquid chromatography-mass spectrometry/mass spectrometryJ Chromatogr B Analyt Technol Biomed Life Sci200582572810.1016/j.jchromb.2004.12.036Open DOISearch in Google Scholar
Yegles M, Mersch F, Wennig R. Detection of benzodiazepines and other psychotropic drugs in human hair by GC/MS. Forensic Sci Int 1997;84:211–8. doi: 10.1016/s0379-0738(96)02064-6YeglesMMerschFWennigRDetection of benzodiazepines and other psychotropic drugs in human hair by GC/MSForensic Sci Int199784211810.1016/s0379-0738(96)02064-6Open DOISearch in Google Scholar
Nakamura M. Analyses of benzodiazepines and their metabolites in various biological matrices by LC-MS (/MS). Biomed Chromatogr 2011;25:1283–307. doi: 10.1002/bmc.1598NakamuraMAnalyses of benzodiazepines and their metabolites in various biological matrices by LC-MS (/MS)Biomed Chromatogr201125128330710.1002/bmc.1598Open DOISearch in Google Scholar
Fukasawa T, Suzuki A, Otani K. Effects of genetic polymorphism of cytochrome P450 enzymes on the pharmacokinetics of benzodiazepines. J Clin Pharm Ther 2007;32:333–41. doi: 10.1111/j.1365-2710.2007.00829.xFukasawaTSuzukiAOtaniKEffects of genetic polymorphism of cytochrome P450 enzymes on the pharmacokinetics of benzodiazepinesJ Clin Pharm Ther2007323334110.1111/j.1365-2710.2007.00829.xOpen DOISearch in Google Scholar
Mizuno K, Katoh M, Okumura H, Nakagawa N, Negishi T, Hashizume T, Nakajima M, Yokoi T. Metabolic activation of benzodiazepines by CYP3A4. Drug Metab Dispos 2009;37:345–51. doi: 10.1124/dmd.108.024521MizunoKKatohMOkumuraHNakagawaNNegishiTHashizumeTNakajimaMYokoiTMetabolic activation of benzodiazepines by CYP3A4Drug Metab Dispos2009373455110.1124/dmd.108.024521Open DOISearch in Google Scholar
Tani N, Ikeda T, Ishikawa T. Relationship between clock gene expression and CYP2C19 and CYP3A4 with benzodiazepines. Hum Exp Toxicol 2023;42:09603271231171643. doi: 10.1177/09603271231171643TaniNIkedaTIshikawaTRelationship between clock gene expression and CYP2C19 and CYP3A4 with benzodiazepinesHum Exp Toxicol2023420960327123117164310.1177/09603271231171643Open DOISearch in Google Scholar
Achour B, Russell MR, Barber J, Rostami-Hodjegan A. Simultaneous quantification of the abundance of several cytochrome P450 and uridine 5′-diphospho-glucuronosyltransferase enzymes in human liver microsomes using multiplexed targeted proteomics. Drug Metab Dispos 2014;42:500–10. doi: 10.1124/dmd.113.055632AchourBRussellMRBarberJRostami-HodjeganASimultaneous quantification of the abundance of several cytochrome P450 and uridine 5′-diphospho-glucuronosyltransferase enzymes in human liver microsomes using multiplexed targeted proteomicsDrug Metab Dispos2014425001010.1124/dmd.113.055632Open DOISearch in Google Scholar
Pettersson Bergstrand M, Meyer MR, Beck O, Helander A. Human urinary metabolic patterns of the designer benzodiazepines flubromazolam and pyrazolam studied by liquid chromatography-high resolution mass spectrometry. Drug Test Anal 2018;10:496–506. doi: 10.1002/dta.2243Pettersson BergstrandMMeyerMRBeckOHelanderAHuman urinary metabolic patterns of the designer benzodiazepines flubromazolam and pyrazolam studied by liquid chromatography-high resolution mass spectrometryDrug Test Anal20181049650610.1002/dta.2243Open DOISearch in Google Scholar
Mandrioli R, Mercolini L, Raggi MA. Benzodiazepine metabolism: an analytical perspective. Curr Drug Metab 2008;9:827–44. doi: 10.2174/138920008786049258MandrioliRMercoliniLRaggiMABenzodiazepine metabolism: an analytical perspectiveCurr Drug Metab200898274410.2174/138920008786049258Open DOISearch in Google Scholar
Griffiths RR, Weerts EM. Benzodiazepine self-administration in humans and laboratory animals-implications for problems of long-term use and abuse. Psychopharmacology (Berl) 1997;134:1–37. doi: 10.1007/s002130050422GriffithsRRWeertsEMBenzodiazepine self-administration in humans and laboratory animals-implications for problems of long-term use and abusePsychopharmacology (Berl)199713413710.1007/s002130050422Open DOISearch in Google Scholar
Wu Q, Hu Y, Wang C, Wei W, Gui L, Zeng W, Liu C, Jia W, Miao J, Lan K. Reevaluate in vitro CYP3A index reactions of benzodiazepines and steroids between humans and dogs. Drug Metab Dispos 2022;50:741–9. doi: 10.1124/dmd.122.000864WuQHuYWangCWeiWGuiLZengWLiuCJiaWMiaoJLanKReevaluate in vitro CYP3A index reactions of benzodiazepines and steroids between humans and dogsDrug Metab Dispos202250741910.1124/dmd.122.000864Open DOISearch in Google Scholar
Buening MK, Chang RL, Huang MT, Fortner JG, Wood AW, Conney AH. Activation and inhibition of benzo (a) pyrene and aflatoxin B1 metabolism in human liver microsomes by naturally occurring flavonoids. Cancer Res 1981;41:67–72. PMID: 7448777BueningMKChangRLHuangMTFortnerJGWoodAWConneyAHActivation and inhibition of benzo (a) pyrene and aflatoxin B1 metabolism in human liver microsomes by naturally occurring flavonoidsCancer Res19814167727448777Search in Google Scholar
Hallifax D, Rawden HC, Hakooz N, Houston JB. Prediction of metabolic clearance using cryopreserved human hepatocytes: kinetic characteristics for five benzodiazepines. Drug Metab Dispos 2005;33:1852–8. doi: 10.1124/dmd.105.005389HallifaxDRawdenHCHakoozNHoustonJBPrediction of metabolic clearance using cryopreserved human hepatocytes: kinetic characteristics for five benzodiazepinesDrug Metab Dispos2005331852810.1124/dmd.105.005389Open DOISearch in Google Scholar
Nishimoto M, Hashimoto H, Ozaki T, Nagashima S, Nakashima M. Effects of antidepressants on the intraventricular conduction and the incidence of arrhythmias induced by programmed ventricular stimulation in the dog heart after myocardial infarction. Naunyn Schmiedebergs Arch Pharmacol 1990;341:240–45. doi: 10.1007/BF00169737NishimotoMHashimotoHOzakiTNagashimaSNakashimaMEffects of antidepressants on the intraventricular conduction and the incidence of arrhythmias induced by programmed ventricular stimulation in the dog heart after myocardial infarctionNaunyn Schmiedebergs Arch Pharmacol19903412404510.1007/BF00169737Open DOISearch in Google Scholar
Broderick PA. Adinazolam affects biogenic amine release in hippocampal CA1 neuronal circuitry. Brain Res Bull 1991;27:689–92. doi: 10.1016/0361-9230(91)90046-MBroderickPAAdinazolam affects biogenic amine release in hippocampal CA1 neuronal circuitryBrain Res Bull1991276899210.1016/0361-9230(91)90046-MOpen DOISearch in Google Scholar
Fleishaker JC, Hulst LK, Ekernäs SÅ, Grahnén A. Pharmacokinetics and pharmacodynamics of adinazolam and N-desmethyladinazolam after oral and intravenous dosing in healthy young and elderly volunteers. J Clin Psychopharmacol 1992;12:403–14. doi: 10.1097/00004714-199212000-00006FleishakerJCHulstLKEkernäsSÅGrahnénAPharmacokinetics and pharmacodynamics of adinazolam and N-desmethyladinazolam after oral and intravenous dosing in healthy young and elderly volunteersJ Clin Psychopharmacol1992124031410.1097/00004714-199212000-00006Open DOISearch in Google Scholar
Bo P, Murelli R, Soragna D, Ferrandi D, Savoldi F. [Electroencephalographic effects of a new triazolobenzodiazepine (Adinazolam) in the rabbit, in Italian]. Boll Soc Ital Biol Sper 1993;69:381–6. PMID: 8148115BoPMurelliRSoragnaDFerrandiDSavoldiF[Electroencephalographic effects of a new triazolobenzodiazepine (Adinazolam) in the rabbit, in Italian]Boll Soc Ital Biol Sper19936938168148115Search in Google Scholar
Turmel A, De Montigny C. Sensitization of rat forebrain neurons to serotonin by adinazolam, an antidepressant triazolobenzodiazepine. Eur J Pharmacol 1984;99:241–4. doi: 10.1016/0014-2999(84)90247-4TurmelADe MontignyCSensitization of rat forebrain neurons to serotonin by adinazolam, an antidepressant triazolobenzodiazepineEur J Pharmacol198499241410.1016/0014-2999(84)90247-4Open DOISearch in Google Scholar
Fleishaker JC, Phillips JP. Adinazolam pharmacokinetics and behavioral effects following administration of 20–60 mg oral doses of its mesylate salt in healthy volunteers. Psychopharmacology 1989;99:34–9. doi: 10.1007/BF00634449FleishakerJCPhillipsJPAdinazolam pharmacokinetics and behavioral effects following administration of 20–60 mg oral doses of its mesylate salt in healthy volunteersPsychopharmacology19899934910.1007/BF00634449Open DOISearch in Google Scholar
Brunetti P, Giorgetti R, Tagliabracci A, Huestis MA, Busardò FP. Designer benzodiazepines: a review of toxicology and public health risks. Pharmaceuticals (Basel) 2021;14(6):560. doi: 10.3390/ph14060560BrunettiPGiorgettiRTagliabracciAHuestisMABusardòFPDesigner benzodiazepines: a review of toxicology and public health risksPharmaceuticals (Basel)202114656010.3390/ph14060560Open DOISearch in Google Scholar
Linnoila M, Stapleton JM, Lister R, Moss H, Lane E, Granger A, Greenblatt DJ, Eckardt MJ. Effects of adinazolam and diazepam, alone and in combination with ethanol, on psychomotor and cognitive performance and on autonomic nervous system reactivity in healthy volunteers. Eur J Clin Pharmacol 1990;38:371–7. doi: 10.1007/BF00315578LinnoilaMStapletonJMListerRMossHLaneEGrangerAGreenblattDJEckardtMJEffects of adinazolam and diazepam, alone and in combination with ethanol, on psychomotor and cognitive performance and on autonomic nervous system reactivity in healthy volunteersEur J Clin Pharmacol199038371710.1007/BF00315578Open DOISearch in Google Scholar
Venkatakrishnan K, Culm KE, Ehrenberg BL, Harmatz JS, Corbett KE, Fleishaker JC, Greenblatt DJ. Kinetics and dynamics of intravenous adinazolam, N-desmethyl adinazolam, and alprazolam in healthy volunteers. J Clin Pharmacol 2005;45:529–37. doi: 10.1177/0091270004269105VenkatakrishnanKCulmKEEhrenbergBLHarmatzJSCorbettKEFleishakerJCGreenblattDJKinetics and dynamics of intravenous adinazolam, N-desmethyl adinazolam, and alprazolam in healthy volunteersJ Clin Pharmacol2005455293710.1177/0091270004269105Open DOISearch in Google Scholar
Maskell PD, Parks C, Button J, Liu H, McKeown DA. Clarification of the correct nomenclature of the amino metabolite of clonazolam: 8-aminoclonazolam. J Anal Toxicol 2021;45(2):e1–2. doi: 10.1093/jat/bkaa169MaskellPDParksCButtonJLiuHMcKeownDAClarification of the correct nomenclature of the amino metabolite of clonazolam: 8-aminoclonazolamJ Anal Toxicol2021452e1210.1093/jat/bkaa169Open DOISearch in Google Scholar
Sommerfeld-Klatta K, Łukasik-Głębocka M, Teżyk A, Panieński P, Żaba C, Zielińska-Psuja B. Clonazolam a new designer benzodiazepine intoxication confirmed by blood concentration. Forensic Sci Int 2020;310:110237. doi: 10.1016/j.forsciint.2020.110237Sommerfeld-KlattaKŁukasik-GłębockaMTeżykAPanieńskiPŻabaCZielińska-PsujaBClonazolam a new designer benzodiazepine intoxication confirmed by blood concentrationForensic Sci Int202031011023710.1016/j.forsciint.2020.110237Open DOISearch in Google Scholar
European Monitoring Centre for Drugs and Drug Addiction. EMCDDA-Europol 2014 Annual Report on the Implementation of Council Decision 2005/387/JHA [displayed12 November 2023]. Available at https://www.emcdda.europa.eu/system/files/publications/1018/TDAN15001ENN.pdfEuropean Monitoring Centre for Drugs and Drug AddictionEMCDDA-Europol 2014 Annual Report on the Implementation of Council Decision 2005/387/JHA [displayed12 November 2023]Available at https://www.emcdda.europa.eu/system/files/publications/1018/TDAN15001ENN.pdfSearch in Google Scholar
El Balkhi S, Chaslot M, Picard N, Dulaurent S, Delage M, Mathieu O, Saint-Marcoux F. Characterization and identification of eight designer benzodiazepine metabolites by incubation with human liver microsomes and analysis by a triple quadrupole mass spectrometer. Int J Legal Med 2017;131:979–88. doi: 10.1007/s00414-017-1541-6El BalkhiSChaslotMPicardNDulaurentSDelageMMathieuOSaint-MarcouxFCharacterization and identification of eight designer benzodiazepine metabolites by incubation with human liver microsomes and analysis by a triple quadrupole mass spectrometerInt J Legal Med20171319798810.1007/s00414-017-1541-6Open DOISearch in Google Scholar
Sommerfeld-Klatta K, Łukasik-Głębocka M, Teżyk A, Panieński P, Żaba C, Zielińska-Psuja B. Clonazolam a new designer benzodiazepine intoxication confirmed by blood concentration. Forensic Sci Int 2020;310:110237. doi: 10.1016/j.forsciint.2020.110237Sommerfeld-KlattaKŁukasik-GłębockaMTeżykAPanieńskiPŻabaCZielińska-PsujaBClonazolam a new designer benzodiazepine intoxication confirmed by blood concentrationForensic Sci Int202031011023710.1016/j.forsciint.2020.110237Open DOISearch in Google Scholar
Runnstrom M, Kalra SS, Lascano J, Patel DC. Overdose from designer benzodiazepine Diclazepam. QJM Int J Med 2020;113:122–4. doi: 10.1093/qjmed/hcz247RunnstromMKalraSSLascanoJPatelDCOverdose from designer benzodiazepine DiclazepamQJM Int J Med2020113122410.1093/qjmed/hcz247Open DOISearch in Google Scholar
Moosmann B, Bisel P, Auwärter V. Characterization of the designer benzodiazepine diclazepam and preliminary data on its metabolism and pharmacokinetics. Drug Test Anal 2014;6:757–63. doi: 10.1002/dta.1628MoosmannBBiselPAuwärterVCharacterization of the designer benzodiazepine diclazepam and preliminary data on its metabolism and pharmacokineticsDrug Test Anal201467576310.1002/dta.1628Open DOISearch in Google Scholar
Nielsen S, McAuley A. Etizolam: A rapid review on pharmacology, non-medical use and harms. Drug Alcohol Rev 2020;39:330–6. doi: 10.1111/dar.13052NielsenSMcAuleyAEtizolam: A rapid review on pharmacology, non-medical use and harmsDrug Alcohol Rev202039330610.1111/dar.13052Open DOISearch in Google Scholar
Al Bahri AA, Hamnett HJ. Etizolam and its major metabolites: a short review. J Anal Toxicol 2023;47:216–26. doi: 10.1093/jat/bkac096Al BahriAAHamnettHJEtizolam and its major metabolites: a short reviewJ Anal Toxicol2023472162610.1093/jat/bkac096Open DOISearch in Google Scholar
O'Connell CW, Sadler CA, Tolia VM, Ly BT, Saitman AM, Fitzgerald RL. Overdose of etizolam: the abuse and rise of a benzodiazepine analog. Ann Emerg Med 2015;65:465–6. doi: 10.1016/j.annemergmed.2014.12.019O'ConnellCWSadlerCAToliaVMLyBTSaitmanAMFitzgeraldRLOverdose of etizolam: the abuse and rise of a benzodiazepine analogAnn Emerg Med201565465610.1016/j.annemergmed.2014.12.019Open DOISearch in Google Scholar
Wagmann L, Manier SK, Bambauer TP, Felske C, Eckstein N, Flockerzi V, Meyer MR. Toxicokinetics and analytical toxicology of flualprazolam: metabolic fate, isozyme mapping, human plasma concentration and main urinary excretion products. J Anal Toxicol 2020;44:549–58. doi: 10.1093/jat/bkaa019WagmannLManierSKBambauerTPFelskeCEcksteinNFlockerziVMeyerMRToxicokinetics and analytical toxicology of flualprazolam: metabolic fate, isozyme mapping, human plasma concentration and main urinary excretion productsJ Anal Toxicol2020445495810.1093/jat/bkaa019Open DOISearch in Google Scholar
Mercurio N, Triebold C, Coleman D. Driving under the influence of flualprazolam: 10 case reports. J Anal Toxicol 2022;46(2):e78–81. doi: 10.1093/jat/bkab105MercurioNTrieboldCColemanDDriving under the influence of flualprazolam: 10 case reportsJ Anal Toxicol2022462e788110.1093/jat/bkab105Open DOISearch in Google Scholar
Kriikku P, Rasanen I, Ojanperä I, Thelander G, Kronstrand R, Vikingsson S. Femoral blood concentrations of flualprazolam in 33 postmortem cases. Forensic Sci Int 2020;307:110101. doi: 10.1016/j.forsciint.2019.110101KriikkuPRasanenIOjanperäIThelanderGKronstrandRVikingssonSFemoral blood concentrations of flualprazolam in 33 postmortem casesForensic Sci Int202030711010110.1016/j.forsciint.2019.110101Open DOISearch in Google Scholar
Moosmann B, Huppertz LM, Hutter M, Buchwald A, Ferlaino S, Auwärter V. Detection and identification of the designer benzodiazepine flubromazepam and preliminary data on its metabolism and pharmacokinetics. J Mass Spectrom 2013;48:1150–9. doi: 10.1002/jms.3279MoosmannBHuppertzLMHutterMBuchwaldAFerlainoSAuwärterVDetection and identification of the designer benzodiazepine flubromazepam and preliminary data on its metabolism and pharmacokineticsJ Mass Spectrom2013481150910.1002/jms.3279Open DOISearch in Google Scholar
Heide G, Høiseth G, Middelkoop G, Øiestad ÅML. Blood concentrations of designer benzodiazepines: relation to impairment and findings in forensic cases. J Anal Toxicol 2020;44:905–14. doi: 10.1093/jat/bkaa043HeideGHøisethGMiddelkoopGØiestadÅMLBlood concentrations of designer benzodiazepines: relation to impairment and findings in forensic casesJ Anal Toxicol2020449051410.1093/jat/bkaa043Open DOISearch in Google Scholar
Huppertz LM, Moosmann B, Auwärter V. Flubromazolam - basic pharmacokinetic evaluation of a highly potent designer benzodiazepine. Drug Test Anal 2018;10:206–11. doi: 10.1002/dta.2203HuppertzLMMoosmannBAuwärterVFlubromazolam - basic pharmacokinetic evaluation of a highly potent designer benzodiazepineDrug Test Anal2018102061110.1002/dta.2203Open DOISearch in Google Scholar
Łukasik-Głębocka M, Sommerfeld K, Teżyk A, Zielińska-Psuja B, Panieński P, Żaba C. Flubromazolam – A new life-threatening designer benzodiazepine. Clin Toxicol 2016;54:66–8. doi: 10.3109/15563650.2015.1112907Łukasik-GłębockaMSommerfeldKTeżykAZielińska-PsujaBPanieńskiPŻabaCFlubromazolam – A new life-threatening designer benzodiazepineClin Toxicol20165466810.3109/15563650.2015.1112907Open DOISearch in Google Scholar
Abdul K, Hikin L, Smith P, Kurimbokus H, Ashong E, Couchman L, Morley SR. Flubromazolam: detection in five post-mortem cases. Med Sci Law 2020;60:266–9. doi: 10.1177/0025802420950273AbdulKHikinLSmithPKurimbokusHAshongECouchmanLMorleySRFlubromazolam: detection in five post-mortem casesMed Sci Law202060266910.1177/0025802420950273Open DOISearch in Google Scholar
Maskell PD, De Paoli G, Nitin Seetohul L, Pounder DJ. Phenazepam: the drug that came in from the cold. J Forensic Leg Med 2012;19:122–5. doi: 10.1016/j.jflm.2011.12.014MaskellPDDe PaoliGNitin SeetohulLPounderDJPhenazepam: the drug that came in from the coldJ Forensic Leg Med201219122510.1016/j.jflm.2011.12.014Open DOISearch in Google Scholar
Stephenson JB, Golz DE, Brasher MJ. Phenazepam and its effects on driving. J Anal Toxicol 2013;37:25–9. doi: 10.1093/jat/bks080StephensonJBGolzDEBrasherMJPhenazepam and its effects on drivingJ Anal Toxicol20133725910.1093/jat/bks080Open DOISearch in Google Scholar
Kriikku P, Wilhelm L, Rintatalo J, Hurme J, Kramer J, Ojanperä I. Phenazepam abuse in Finland: findings from apprehended drivers, post-mortem cases and police confiscations. Forensic Sci Int 2012;220:111–7. doi: 10.1016/j.forsciint.2012.02.006KriikkuPWilhelmLRintataloJHurmeJKramerJOjanperäIPhenazepam abuse in Finland: findings from apprehended drivers, post-mortem cases and police confiscationsForensic Sci Int2012220111710.1016/j.forsciint.2012.02.006Open DOISearch in Google Scholar
Corkery JM, Schifano F, Ghodse AH. Phenazepam abuse in the UK: an emerging problem causing serious adverse health problems, including death. Hum Psychopharmacol Clin Exp 2012;27:254–61. doi: 10.1002/hup.2222CorkeryJMSchifanoFGhodseAHPhenazepam abuse in the UK: an emerging problem causing serious adverse health problems, including deathHum Psychopharmacol Clin Exp2012272546110.1002/hup.2222Open DOISearch in Google Scholar
Hester JB Jr, Von Voigtlander P. 6-Aryl-4H-s-triazolo [4, 3-a][1, 4] benzodiazepines. Influence of 1-substitution on pharmacological activity. J Med Chem 1979;22:1390–8. doi: 10.1021/jm00197a021HesterJBJrVon VoigtlanderP6-Aryl-4H-s-triazolo [4, 3-a][1, 4] benzodiazepine. Influence of 1-substitution on pharmacological activityJ Med Chem1979221390810.1021/jm00197a021Open DOISearch in Google Scholar
European Monitoring Centre for Drugs and Drug Addiction. Annual report 2021 on the state of the drugs problem in Europe [displayed 24 November 2023]. Available at https://www.emcdda.europa.eu/system/files/media/publications/documents/973/TDAC12001ENC_.pdfEuropean Monitoring Centre for Drugs and Drug AddictionAnnual report 2021 on the state of the drugs problem in Europe [displayed 24 November 2023]Available at https://www.emcdda.europa.eu/system/files/media/publications/documents/973/TDAC12001ENC_.pdfSearch in Google Scholar
Moosmann B, Hutter M, Huppertz LM, Ferlaino S, Redlingshöfer L, Auwärter V. Characterization of the designer benzodiazepine pyrazolam and its detectability in human serum and urine. Forensic Toxicol 2013;31:263–71. doi: 10.1007/s11419-013-0187-4MoosmannBHutterMHuppertzLMFerlainoSRedlingshöferLAuwärterVCharacterization of the designer benzodiazepine pyrazolam and its detectability in human serum and urineForensic Toxicol2013312637110.1007/s11419-013-0187-4Open DOISearch in Google Scholar
Lehmann S, Sczyslo A, Froch-Cortis J, Rothschild MA, Thevis M, Andresen-Streichert H, Mercer-Chalmers-Bender K. Organ distribution of diclazepam, pyrazolam and 3-fluorophenmetrazine. Forensic Sci Int 2019;303:109959. doi: 10.1016/j.forsciint.2019.109959LehmannSSczysloAFroch-CortisJRothschildMAThevisMAndresen-StreichertHMercer-Chalmers-BenderKOrgan distribution of diclazepam, pyrazolam and 3-fluorophenmetrazineForensic Sci Int201930310995910.1016/j.forsciint.2019.109959Open DOISearch in Google Scholar
Pettersson Bergstrand M, Helander A, Beck O. Development and application of a multi-component LC–MS/MS method for determination of designer benzodiazepines in urine. J Chromatogr B Analyt Technol Biomed Life Sci 2016;1035:104–10. doi: 10.1016/j.jchromb.2016.08.047Pettersson BergstrandMHelanderABeckODevelopment and application of a multi-component LC–MS/MS method for determination of designer benzodiazepines in urineJ Chromatogr B Analyt Technol Biomed Life Sci201610351041010.1016/j.jchromb.2016.08.047Open DOISearch in Google Scholar
Mastrovito RA, Papsun DM, Logan BK. The development and validation of a novel designer benzodiazepines panel by LC–MS-MS. J Anal Toxicol 2021;45:423–8. doi: 10.1093/jat/bkab013MastrovitoRAPapsunDMLoganBKThe development and validation of a novel designer benzodiazepines panel by LC–MS-MSJ Anal Toxicol202145423810.1093/jat/bkab013Open DOISearch in Google Scholar
Behnoush B, Sheikhazadi A, Bazmi E, Fattahi A, Sheikhazadi E, Saberi Anary SH. Comparison of UHPLC and HPLC in benzodiazepines analysis of postmortem samples: a case-control study. Medicine (Baltimore) 2015;94(14):e640. doi: 10.1097/MD.0000000000000640BehnoushBSheikhazadiABazmiEFattahiASheikhazadiESaberi AnarySHComparison of UHPLC and HPLC in benzodiazepines analysis of postmortem samples: a case-control studyMedicine (Baltimore)20159414e64010.1097/MD.0000000000000640Open DOISearch in Google Scholar
Vårdal L, Wong G, Øiestad ÅML, Pedersen-Bjergaard S, Gjelstad A, Øiestad EL. Rapid determination of designer benzodiazepines, benzodiazepines, and Z-hypnotics in whole blood using parallel artificial liquid membrane extraction and UHPLC-MS/MS. Anal Bioanal Chem 2018;410:4967–78. doi: 10.1007/s00216-018-1147-yVårdalLWongGØiestadÅMLPedersen-BjergaardSGjelstadAØiestadELRapid determination of designer benzodiazepines, benzodiazepines, and Z-hypnotics in whole blood using parallel artificial liquid membrane extraction and UHPLC-MS/MSAnal Bioanal Chem201841049677810.1007/s00216-018-1147-yOpen DOISearch in Google Scholar
Schaefer N, Peters B, Schmidt P, Ewald AH. Development and validation of two LC-MS/MS methods for the detection and quantification of amphetamines, designer amphetamines, benzoylecgonine, benzodiazepines, opiates, and opioids in urine using turbulent flow chromatography. Anal Bioanal Chem 2013;405:247–58. doi: 10.1007/s00216-012-6458-9SchaeferNPetersBSchmidtPEwaldAHDevelopment and validation of two LC-MS/MS methods for the detection and quantification of amphetamines, designer amphetamines, benzoylecgonine, benzodiazepines, opiates, and opioids in urine using turbulent flow chromatographyAnal Bioanal Chem20134052475810.1007/s00216-012-6458-9Open DOISearch in Google Scholar
Racamonde I, Rodil R, Quintana JB, Villaverde-de-Sáa E, Cela R. Determination of benzodiazepines, related pharmaceuticals and metabolites in water by solid-phase extraction and liquid-chromatography-tandem mass spectrometry. J Chromatogr A 2014;1352:69–79. doi: 10.1016/j.chroma.2014.05.064RacamondeIRodilRQuintanaJBVillaverde-de-SáaECelaRDetermination of benzodiazepines, related pharmaceuticals and metabolites in water by solid-phase extraction and liquid-chromatography-tandem mass spectrometryJ Chromatogr A20141352697910.1016/j.chroma.2014.05.064Open DOISearch in Google Scholar
Nissilä T, Backman N, Kolmonen M, Leinonen A, Kiriazis A, Yli-Kauhaluoma J, Sainiemi L, Kostiainen R, Franssila S, Ketola RA. Rotating multitip micropillar array electrospray ionization-mass spectrometry for rapid analysis and high-throughput screening. Int J Mass Spectrom 2012;310:65–71. doi: 10.1016/j.ijms.2011.11.013NissiläTBackmanNKolmonenMLeinonenAKiriazisAYli-KauhaluomaJSainiemiLKostiainenRFranssilaSKetolaRARotating multitip micropillar array electrospray ionization-mass spectrometry for rapid analysis and high-throughput screeningInt J Mass Spectrom2012310657110.1016/j.ijms.2011.11.013Open DOISearch in Google Scholar
O'Donnell RM, Sun X, Harrington P de B. Pharmaceutical applications of ion mobility spectrometry. TrAC Trends Anal Chem 2008;27:44–53. doi: 10.1016/j.trac.2007.10.014O'DonnellRMSunXHarringtonP de BPharmaceutical applications of ion mobility spectrometryTrAC Trends Anal Chem200827445310.1016/j.trac.2007.10.014Open DOISearch in Google Scholar
Atkinson K, Beretta E, Brown J, Castrodad M, Chen Y, Cosgrove J, Du P, Litchfield J, Makowski M, Martin K, McLellan TJ, Neagu C, Perry DA, Piotrowski DW, Steppan CM, Trilles R. N-benzylimidazole carboxamides as potent, orally active stearoylCoA desaturase-1 inhibitors. Bioorg Med Chem Lett 2011;21:1621–5. doi: 10.1016/j.bmcl.2011.01.113AtkinsonKBerettaEBrownJCastrodadMChenYCosgroveJDuPLitchfieldJMakowskiMMartinKMcLellanTJNeaguCPerryDAPiotrowskiDWSteppanCMTrillesRN-benzylimidazole carboxamides as potent, orally active stearoylCoA desaturase-1 inhibitorsBioorg Med Chem Lett2011211621510.1016/j.bmcl.2011.01.113Open DOISearch in Google Scholar
McIntire GL, Morris AA, Hitchcock JC, Enders J. Rapid analysis of selected benzodiazepines by automated SPE–MS-MS. LCGC Suppl 2015;13(2):8–15.McIntireGLMorrisAAHitchcockJCEndersJRapid analysis of selected benzodiazepines by automated SPE–MS-MSLCGC Suppl2015132815Search in Google Scholar
Beduk D, Beduk T, de Oliveira Filho JI, Ait Lahcen A, Aldemir E, Guler Celik E, Timur S. Smart multiplex point-of-care platform for simultaneous drug monitoring. ACS Appl Mater Interfaces 2023;15:37247–58. doi: 10.1021/acsami.3c06461BedukDBedukTde Oliveira FilhoJIAit LahcenAAldemirEGuler CelikETimurSSmart multiplex point-of-care platform for simultaneous drug monitoringACS Appl Mater Interfaces202315372475810.1021/acsami.3c06461Open DOISearch in Google Scholar
de Jong LAA, Jeronimus-Stratingh CM, Cremers TIFH. Development of a multiplex non-radioactive receptor assay: the benzodiazepine receptor, the serotonin transporter and the β-adrenergic receptor. Rapid Commun Mass Spectrom 2007;21:567–72. doi: 10.1002/rcm.2869de JongLAAJeronimus-StratinghCMCremersTIFHDevelopment of a multiplex non-radioactive receptor assay: the benzodiazepine receptor, the serotonin transporter and the β-adrenergic receptorRapid Commun Mass Spectrom2007215677210.1002/rcm.2869Open DOISearch in Google Scholar
Fitzgerald RL, Rexin DA, Herold DA. Detecting benzodiazepines: immunoassays compared with negative chemical ionization gas chromatography/mass spectrometry. Clin Chem 1994;40:373–80. doi: 10.1093/clinchem/40.3.373FitzgeraldRLRexinDAHeroldDADetecting benzodiazepines: immunoassays compared with negative chemical ionization gas chromatography/mass spectrometryClin Chem1994403738010.1093/clinchem/40.3.373Open DOISearch in Google Scholar
Wang J, Wang Y, Pan Y, Feng L, Chen D, Liu Z, Peng D, Yuan Z. Preparation of a broadly specific monoclonal antibody-based indirect competitive ELISA for the detection of benzodiazepines in edible animal tissues and feed. Food Anal Methods 2016;9:3407–19. doi: 10.1007/s12161-016-0528-0WangJWangYPanYFengLChenDLiuZPengDYuanZPreparation of a broadly specific monoclonal antibody-based indirect competitive ELISA for the detection of benzodiazepines in edible animal tissues and feedFood Anal Methods2016934071910.1007/s12161-016-0528-0Open DOISearch in Google Scholar
Darragh A, Snyder ML, Ptolemy AS, Melanson S. KIMS, CEDIA, and HS-CEDIA immunoassays are inadequately sensitive for detection of benzodiazepines in urine from patients treated for chronic pain. Pain Physician 2014;17:359–66. PMID: 25054395DarraghASnyderMLPtolemyASMelansonSKIMS, CEDIA, and HS-CEDIA immunoassays are inadequately sensitive for detection of benzodiazepines in urine from patients treated for chronic painPain Physician2014173596625054395Search in Google Scholar
Bertol E, Vaiano F, Furlanetto S, Mari F. Cross-reactivities and structure-reactivity relationships of six benzodiazepines to EMIT® immunoassay. J Pharm Biomed Anal 2013;84:168–72. doi: 10.1016/j.jpba.2013.05.026BertolEVaianoFFurlanettoSMariFCross-reactivities and structure-reactivity relationships of six benzodiazepines to EMIT® immunoassayJ Pharm Biomed Anal2013841687210.1016/j.jpba.2013.05.026Open DOISearch in Google Scholar
Moretti M, Freni F, Tomaciello I, Vignali C, Groppi A, Visonà SD, Tajana L, Osculati AMM, Morini L. Determination of benzodiazepines in blood and in dried blood spots collected from post-mortem samples and evaluation of the stability over a three-month period. Drug Test Anal 2019;11:1403–11. doi: 10.1002/dta.2653MorettiMFreniFTomacielloIVignaliCGroppiAVisonàSDTajanaLOsculatiAMMMoriniLDetermination of benzodiazepines in blood and in dried blood spots collected from post-mortem samples and evaluation of the stability over a three-month periodDrug Test Anal20191114031110.1002/dta.2653Open DOISearch in Google Scholar
Mestad IO, Gjelstad A, Pedersen-Bjergaard S, Øiestad EL. Green and sustainable drug analysis - Combining microsampling and microextraction of drugs of abuse. Sustain Chem Pharm 2021;24(7):100517. doi: 10.1016/j.scp.2021.100517MestadIOGjelstadAPedersen-BjergaardSØiestadELGreen and sustainable drug analysis - Combining microsampling and microextraction of drugs of abuseSustain Chem Pharm202124710051710.1016/j.scp.2021.100517Open DOISearch in Google Scholar
Gundersen POM, Broecker S, Slørdal L, Spigset O, Josefsson M. Retrospective screening of synthetic cannabinoids, synthetic opioids and designer benzodiazepines in data files from forensic post mortem samples analysed by UHPLC-QTOF-MS from 2014 to 2018. Forensic Sci Int 2020;311:110274. doi: 10.1016/j.forsciint.2020.110274GundersenPOMBroeckerSSlørdalLSpigsetOJosefssonMRetrospective screening of synthetic cannabinoids, synthetic opioids and designer benzodiazepines in data files from forensic post mortem samples analysed by UHPLC-QTOF-MS from 2014 to 2018Forensic Sci Int202031111027410.1016/j.forsciint.2020.110274Open DOISearch in Google Scholar
Yao W, Fan Z, Zhang S. Poly(N-vinylcarbazole-co-divinylbenzene) monolith microextraction coupled to liquid chromatography-high resolution Orbitrap mass spectrometry to analyse benzodiazepines in beer and urine. J Chromatogr A 2016;1465:55–62. doi: 10.1016/j.chroma.2016.08.064YaoWFanZZhangSPoly(N-vinylcarbazole-co-divinylbenzene) monolith microextraction coupled to liquid chromatography-high resolution Orbitrap mass spectrometry to analyse benzodiazepines in beer and urineJ Chromatogr A20161465556210.1016/j.chroma.2016.08.064Open DOISearch in Google Scholar